Local view for "http://purl.org/linkedpolitics/eu/plenary/2002-04-09-Speech-2-172"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20020409.7.2-172"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:translated text |
".
Mr President, please forgive me but the necessary speed required by the time limits this House manages so well have prevented me from replying to the honourable Member. I am very happy to do so.
Firstly, I must point out that the honourable Member’s information does not coincide with ours. According to my information, which should not be declassified at the moment, we can rest assured that ammunition containing depleted uranium has not been used in Afghanistan and this has also been indicated by the units with NBC detection equipment within Afghanistan itself, within the ISAF.
Secondly, and with regard to your question on what protection measures had been taken: apart from being supplied with NBC detection equipment, in the units which the various countries have deployed, either in Kabul, or – as in the Spanish case – in Bagram, the medical units observe very strict rules of conduct and carry out constant monitoring, both of this type of injury in terms of health, and of the risks resulting from the internal situation of the country and any resistance.
Thirdly, I must point out that the Belgian Presidency began a study, which is being continued by the Spanish Presidency, on the most appropriate measures for safeguarding the health of troops. And finally I must tell the honourable Member that the scientists who studied the problem in Spain – and they were independent academic and clinical scientists – guaranteed that no direct relationship between the use of depleted uranium and certain tumours observed amongst some combatants could be established."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples